Xiangdong Qu is the founder of QureBio. QureBio has raised $45M in total funding. Latest round: Series C. Backed by Efung Capital. Based in Shanghai, China.
Xiangdong Qu is the founder of QureBio, a biopharmaceutical company established in 2017 in Shanghai, China. QureBio specializes in the research and development of innovative bispecific and multispecific antibody and protein therapeutics for oncology, autoimmune diseases, and inflammatory disorders. The company recently completed a Series C1 financing round, raising nearly CNY 100 million (approximately USD 14 million) to accelerate clinical trials and advance its pipeline.
Full founder directory · Investor directory · Company funding database · Fundraising library